Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01.10.2020 → 30.10.2024 |
Fields of science
- 302 Clinical Medicine
- 302035 Paediatrics and adolescent medicine
A Phase 1/2 , Open-label Multicenter, Non-randomized Study to Assess the Safety, tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Age with X-linked Hypophosphatemia (XLH)
- Högler, Wolfgang (PI)
Project: Contract research › Industry project